Sage Rhino Capital LLC Novartis Ag Transaction History

Sage Rhino Capital LLC

$446 Million
Q4 2024

A detailed history of Sage Rhino Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Sage Rhino Capital LLC holds 7,847 shares of NVS stock, worth $873,763. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,847

Previous 8,166 3.91%

Holding current value

$873,763

Previous $939,000 18.74%

% of portfolio

0.17%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$96.78 - $117.18 $30,872 - $37,380	-319 Reduced 3.91%	7,847 $763,000
Q3 2024 Nov 01, 2024	BUY	$106.13 - $120.89 $33,855 - $38,563	319 Added 4.07%	8,166 $939,000
Q2 2024 Jul 30, 2024	BUY	$92.57 - $107.37 $3,795 - $4,402	41 Added 0.53%	7,847 $835,000
Q1 2024 Apr 26, 2024	BUY	$95.27 - $108.47 $15,433 - $17,572	162 Added 2.12%	7,806 $755,000
Q4 2023 Feb 05, 2024	BUY	$92.27 - $101.54 $6,458 - $7,107	70 Added 0.92%	7,644 $771,000
Q3 2023 Oct 26, 2023	BUY	$94.73 - $105.13 $36,376 - $40,369	384 Added 5.34%	7,574 $771,000
Q2 2023 Jul 31, 2023	BUY	$92.52 - $104.91 $24,702 - $28,010	267 Added 3.86%	7,190 $725,000
Q1 2023 Apr 20, 2023	BUY	$80.03 - $92.81 $9,603 - $11,137	120 Added 1.76%	6,923 $636,000
Q4 2022 Jan 31, 2023	BUY	$75.55 - $92.52 $30,144 - $36,915	399 Added 6.23%	6,803 $617,000
Q3 2022 Oct 24, 2022	SELL	$74.61 - $87.26 $83,936 - $98,167	-1,125 Reduced 14.94%	6,404 $487,000
Q2 2022 Jul 28, 2022	BUY	$80.52 - $93.75 $61,597 - $71,718	765 Added 11.31%	7,529 $636,000
Q1 2022 Apr 27, 2022	BUY	$80.11 - $90.62 $60,082 - $67,965	750 Added 12.47%	6,764 $594,000
Q4 2021 Feb 04, 2022	BUY	$79.7 - $88.13 $13,708 - $15,158	172 Added 2.94%	6,014 $526,000
Q3 2021 Oct 18, 2021	BUY	$81.78 - $95.14 $3,925 - $4,566	48 Added 0.83%	5,842 $478,000
Q2 2021 Jul 27, 2021	BUY	$85.24 - $94.15 $48,075 - $53,100	564 Added 10.78%	5,794 $529,000
Q1 2021 May 04, 2021	BUY	$83.5 - $98.47 $14,278 - $16,838	171 Added 3.38%	5,230 $447,000
Q4 2020 Feb 03, 2021	BUY	$78.07 - $94.43 $312 - $377	4 Added 0.08%	5,059 $478,000
Q3 2020 Nov 05, 2020	SELL	$82.14 - $91.0 $8,953 - $9,919	-109 Reduced 2.11%	5,055 $440,000
Q2 2020 Jul 30, 2020	BUY	$80.93 - $91.1 $33,585 - $37,806	415 Added 8.74%	5,164 $451,000
Q1 2020 Apr 29, 2020	BUY	$70.67 - $99.01 $1,837 - $2,574	26 Added 0.55%	4,749 $392,000
Q4 2019 Jan 31, 2020	BUY	$84.35 - $95.37 $3,542 - $4,005	42 Added 0.9%	4,723 $443,000
Q3 2019 Oct 25, 2019	SELL	$85.54 - $94.26 $6,672 - $7,352	-78 Reduced 1.64%	4,681 $407,000
Q2 2019 Aug 20, 2019	BUY	$75.4 - $92.8 $13,798 - $16,982	183 Added 4.0%	4,759 $435,000
Q1 2019 Apr 18, 2019	BUY	$75.32 - $86.15 $344,664 - $394,222	4,576 New	4,576 $440,000

Others Institutions Holding NVS

# of Institutions

1,479

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Novartis Ag Transaction History